IDEAYA Biosciences to Participate in the 2023 Guggenheim Oncology Conference
February 1, 2023
Todos Medical Terminates Tollovid(TM) Products License & Distribution Agreement with T-Cell Protect Hellas S.A.
November 10, 2022
Related Post
-
-
Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed
February 1, 2023
-
ChromaDex Shares Promising Findings from a Clinical Study Showcasing Combined Metabolic Activators (CMAs), Featuring Nicotinamide Riboside (NR), Improved Cognitive Functions in Alzheimer’s Disease (AD) Patients
January 31, 2023
-
Silo Pharma Announces Stock Repurchase Program
January 31, 2023